Publication Information

{'id': 'https://openalex.org/W1989308735', 'doi': 'https://doi.org/10.1200/jco.2010.34.1248', 'title': 'Evaluation of Oncology Drugs at the European Medicines Agency and US Food and Drug Administration: When Differences Have an Impact on Clinical Practice', 'display_name': 'Evaluation of Oncology Drugs at the European Medicines Agency and US Food and Drug Administration: When Differences Have an Impact on Clinical Practice', 'publication_year': 2011, 'publication_date': '2011-05-03', 'ids': {'openalex': 'https://openalex.org/W1989308735', 'doi': 'https://doi.org/10.1200/jco.2010.34.1248', 'mag': '1989308735', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/21537038'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1200/jco.2010.34.1248', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S15137598', 'display_name': 'Journal of Clinical Oncology', 'issn_l': '0732-183X', 'issn': ['0732-183X', '1527-7755'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5068196173', 'display_name': 'Francesco Trotta', 'orcid': 'https://orcid.org/0000-0001-6889-8484'}, 'institutions': [{'id': 'https://openalex.org/I4210150351', 'display_name': 'Medicines Evaluation Board', 'ror': 'https://ror.org/05mv4rb84', 'country_code': 'NL', 'type': 'education', 'lineage': ['https://openalex.org/I4210150351']}, {'id': 'https://openalex.org/I193662353', 'display_name': 'Utrecht University', 'ror': 'https://ror.org/04pp8hn57', 'country_code': 'NL', 'type': 'education', 'lineage': ['https://openalex.org/I193662353']}, {'id': 'https://openalex.org/I4210116535', 'display_name': 'Italian Medicines Agency', 'ror': 'https://ror.org/01ttmqc18', 'country_code': 'IT', 'type': 'government', 'lineage': ['https://openalex.org/I2801313885', 'https://openalex.org/I2802886945', 'https://openalex.org/I4210104593', 'https://openalex.org/I4210116535']}], 'countries': ['IT', 'NL'], 'is_corresponding': False, 'raw_author_name': 'Francesco Trotta', 'raw_affiliation_strings': ['Franceso Trotta, Giovanni Tafuri, Italian Medicines Agency, Rome, Italy; Hubert G.M. Leufkens, Jan H.M. Schellens, Giovanni Tafuri, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht; Hubert G.M. Leufkens, Jan H.M. Schellens, Medicines Evaluation Board, The Hague; Jan H.M. Schellens, The Netherlands Cancer Institute, Amsterdam, the Netherlands; and Richard Laing, WHO, Geneva, Switzerland.'], 'affiliations': [{'raw_affiliation_string': 'Franceso Trotta, Giovanni Tafuri, Italian Medicines Agency, Rome, Italy; Hubert G.M. Leufkens, Jan H.M. Schellens, Giovanni Tafuri, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht; Hubert G.M. Leufkens, Jan H.M. Schellens, Medicines Evaluation Board, The Hague; Jan H.M. Schellens, The Netherlands Cancer Institute, Amsterdam, the Netherlands; and Richard Laing, WHO, Geneva, Switzerland.', 'institution_ids': ['https://openalex.org/I4210150351', 'https://openalex.org/I193662353', 'https://openalex.org/I4210116535']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5108247103', 'display_name': 'Hubert G.M. Leufkens', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210150351', 'display_name': 'Medicines Evaluation Board', 'ror': 'https://ror.org/05mv4rb84', 'country_code': 'NL', 'type': 'education', 'lineage': ['https://openalex.org/I4210150351']}, {'id': 'https://openalex.org/I193662353', 'display_name': 'Utrecht University', 'ror': 'https://ror.org/04pp8hn57', 'country_code': 'NL', 'type': 'education', 'lineage': ['https://openalex.org/I193662353']}, {'id': 'https://openalex.org/I4210116535', 'display_name': 'Italian Medicines Agency', 'ror': 'https://ror.org/01ttmqc18', 'country_code': 'IT', 'type': 'government', 'lineage': ['https://openalex.org/I2801313885', 'https://openalex.org/I2802886945', 'https://openalex.org/I4210104593', 'https://openalex.org/I4210116535']}], 'countries': ['IT', 'NL'], 'is_corresponding': False, 'raw_author_name': 'Hubert G.M. Leufkens', 'raw_affiliation_strings': ['Franceso Trotta, Giovanni Tafuri, Italian Medicines Agency, Rome, Italy; Hubert G.M. Leufkens, Jan H.M. Schellens, Giovanni Tafuri, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht; Hubert G.M. Leufkens, Jan H.M. Schellens, Medicines Evaluation Board, The Hague; Jan H.M. Schellens, The Netherlands Cancer Institute, Amsterdam, the Netherlands; and Richard Laing, WHO, Geneva, Switzerland.'], 'affiliations': [{'raw_affiliation_string': 'Franceso Trotta, Giovanni Tafuri, Italian Medicines Agency, Rome, Italy; Hubert G.M. Leufkens, Jan H.M. Schellens, Giovanni Tafuri, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht; Hubert G.M. Leufkens, Jan H.M. Schellens, Medicines Evaluation Board, The Hague; Jan H.M. Schellens, The Netherlands Cancer Institute, Amsterdam, the Netherlands; and Richard Laing, WHO, Geneva, Switzerland.', 'institution_ids': ['https://openalex.org/I4210150351', 'https://openalex.org/I193662353', 'https://openalex.org/I4210116535']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5000418012', 'display_name': 'Jan H.M. Schellens', 'orcid': 'https://orcid.org/0000-0001-6832-1976'}, 'institutions': [{'id': 'https://openalex.org/I4210150351', 'display_name': 'Medicines Evaluation Board', 'ror': 'https://ror.org/05mv4rb84', 'country_code': 'NL', 'type': 'education', 'lineage': ['https://openalex.org/I4210150351']}, {'id': 'https://openalex.org/I193662353', 'display_name': 'Utrecht University', 'ror': 'https://ror.org/04pp8hn57', 'country_code': 'NL', 'type': 'education', 'lineage': ['https://openalex.org/I193662353']}, {'id': 'https://openalex.org/I4210116535', 'display_name': 'Italian Medicines Agency', 'ror': 'https://ror.org/01ttmqc18', 'country_code': 'IT', 'type': 'government', 'lineage': ['https://openalex.org/I2801313885', 'https://openalex.org/I2802886945', 'https://openalex.org/I4210104593', 'https://openalex.org/I4210116535']}], 'countries': ['IT', 'NL'], 'is_corresponding': False, 'raw_author_name': 'Jan H.M. Schellens', 'raw_affiliation_strings': ['Franceso Trotta, Giovanni Tafuri, Italian Medicines Agency, Rome, Italy; Hubert G.M. Leufkens, Jan H.M. Schellens, Giovanni Tafuri, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht; Hubert G.M. Leufkens, Jan H.M. Schellens, Medicines Evaluation Board, The Hague; Jan H.M. Schellens, The Netherlands Cancer Institute, Amsterdam, the Netherlands; and Richard Laing, WHO, Geneva, Switzerland.'], 'affiliations': [{'raw_affiliation_string': 'Franceso Trotta, Giovanni Tafuri, Italian Medicines Agency, Rome, Italy; Hubert G.M. Leufkens, Jan H.M. Schellens, Giovanni Tafuri, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht; Hubert G.M. Leufkens, Jan H.M. Schellens, Medicines Evaluation Board, The Hague; Jan H.M. Schellens, The Netherlands Cancer Institute, Amsterdam, the Netherlands; and Richard Laing, WHO, Geneva, Switzerland.', 'institution_ids': ['https://openalex.org/I4210150351', 'https://openalex.org/I193662353', 'https://openalex.org/I4210116535']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5021601421', 'display_name': 'Richard Laing', 'orcid': 'https://orcid.org/0000-0002-3825-217X'}, 'institutions': [{'id': 'https://openalex.org/I4210150351', 'display_name': 'Medicines Evaluation Board', 'ror': 'https://ror.org/05mv4rb84', 'country_code': 'NL', 'type': 'education', 'lineage': ['https://openalex.org/I4210150351']}, {'id': 'https://openalex.org/I193662353', 'display_name': 'Utrecht University', 'ror': 'https://ror.org/04pp8hn57', 'country_code': 'NL', 'type': 'education', 'lineage': ['https://openalex.org/I193662353']}, {'id': 'https://openalex.org/I4210116535', 'display_name': 'Italian Medicines Agency', 'ror': 'https://ror.org/01ttmqc18', 'country_code': 'IT', 'type': 'government', 'lineage': ['https://openalex.org/I2801313885', 'https://openalex.org/I2802886945', 'https://openalex.org/I4210104593', 'https://openalex.org/I4210116535']}], 'countries': ['IT', 'NL'], 'is_corresponding': False, 'raw_author_name': 'Richard Laing', 'raw_affiliation_strings': ['Franceso Trotta, Giovanni Tafuri, Italian Medicines Agency, Rome, Italy; Hubert G.M. Leufkens, Jan H.M. Schellens, Giovanni Tafuri, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht; Hubert G.M. Leufkens, Jan H.M. Schellens, Medicines Evaluation Board, The Hague; Jan H.M. Schellens, The Netherlands Cancer Institute, Amsterdam, the Netherlands; and Richard Laing, WHO, Geneva, Switzerland.'], 'affiliations': [{'raw_affiliation_string': 'Franceso Trotta, Giovanni Tafuri, Italian Medicines Agency, Rome, Italy; Hubert G.M. Leufkens, Jan H.M. Schellens, Giovanni Tafuri, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht; Hubert G.M. Leufkens, Jan H.M. Schellens, Medicines Evaluation Board, The Hague; Jan H.M. Schellens, The Netherlands Cancer Institute, Amsterdam, the Netherlands; and Richard Laing, WHO, Geneva, Switzerland.', 'institution_ids': ['https://openalex.org/I4210150351', 'https://openalex.org/I193662353', 'https://openalex.org/I4210116535']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5007531158', 'display_name': 'Giovanni Tafuri', 'orcid': 'https://orcid.org/0000-0002-9283-0153'}, 'institutions': [{'id': 'https://openalex.org/I4210150351', 'display_name': 'Medicines Evaluation Board', 'ror': 'https://ror.org/05mv4rb84', 'country_code': 'NL', 'type': 'education', 'lineage': ['https://openalex.org/I4210150351']}, {'id': 'https://openalex.org/I193662353', 'display_name': 'Utrecht University', 'ror': 'https://ror.org/04pp8hn57', 'country_code': 'NL', 'type': 'education', 'lineage': ['https://openalex.org/I193662353']}, {'id': 'https://openalex.org/I4210116535', 'display_name': 'Italian Medicines Agency', 'ror': 'https://ror.org/01ttmqc18', 'country_code': 'IT', 'type': 'government', 'lineage': ['https://openalex.org/I2801313885', 'https://openalex.org/I2802886945', 'https://openalex.org/I4210104593', 'https://openalex.org/I4210116535']}], 'countries': ['IT', 'NL'], 'is_corresponding': False, 'raw_author_name': 'Giovanni Tafuri', 'raw_affiliation_strings': ['Franceso Trotta, Giovanni Tafuri, Italian Medicines Agency, Rome, Italy; Hubert G.M. Leufkens, Jan H.M. Schellens, Giovanni Tafuri, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht; Hubert G.M. Leufkens, Jan H.M. Schellens, Medicines Evaluation Board, The Hague; Jan H.M. Schellens, The Netherlands Cancer Institute, Amsterdam, the Netherlands; and Richard Laing, WHO, Geneva, Switzerland.'], 'affiliations': [{'raw_affiliation_string': 'Franceso Trotta, Giovanni Tafuri, Italian Medicines Agency, Rome, Italy; Hubert G.M. Leufkens, Jan H.M. Schellens, Giovanni Tafuri, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht; Hubert G.M. Leufkens, Jan H.M. Schellens, Medicines Evaluation Board, The Hague; Jan H.M. Schellens, The Netherlands Cancer Institute, Amsterdam, the Netherlands; and Richard Laing, WHO, Geneva, Switzerland.', 'institution_ids': ['https://openalex.org/I4210150351', 'https://openalex.org/I193662353', 'https://openalex.org/I4210116535']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 3, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 12.9, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 71, 'citation_normalized_percentile': {'value': 0.99998, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 96, 'max': 97}, 'biblio': {'volume': '29', 'issue': '16', 'first_page': '2266', 'last_page': '2272'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10804', 'display_name': 'Health Systems, Economic Evaluations, Quality of Life', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2002', 'display_name': 'Economics and Econometrics'}, 'field': {'id': 'https://openalex.org/fields/20', 'display_name': 'Economics, Econometrics and Finance'}, 'domain': {'id': 'https://openalex.org/domains/2', 'display_name': 'Social Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10804', 'display_name': 'Health Systems, Economic Evaluations, Quality of Life', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2002', 'display_name': 'Economics and Econometrics'}, 'field': {'id': 'https://openalex.org/fields/20', 'display_name': 'Economics, Econometrics and Finance'}, 'domain': {'id': 'https://openalex.org/domains/2', 'display_name': 'Social Sciences'}}, {'id': 'https://openalex.org/T11792', 'display_name': 'Pharmaceutical Economics and Policy', 'score': 0.9966, 'subfield': {'id': 'https://openalex.org/subfields/2002', 'display_name': 'Economics and Econometrics'}, 'field': {'id': 'https://openalex.org/fields/20', 'display_name': 'Economics, Econometrics and Finance'}, 'domain': {'id': 'https://openalex.org/domains/2', 'display_name': 'Social Sciences'}}, {'id': 'https://openalex.org/T11235', 'display_name': 'Statistical Methods in Clinical Trials', 'score': 0.9947, 'subfield': {'id': 'https://openalex.org/subfields/2613', 'display_name': 'Statistics and Probability'}, 'field': {'id': 'https://openalex.org/fields/26', 'display_name': 'Mathematics'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/clinical-practice', 'display_name': 'Clinical Practice', 'score': 0.4446321}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8920027}, {'id': 'https://openalex.org/C3018890749', 'wikidata': 'https://www.wikidata.org/wiki/Q204711', 'display_name': 'Food and drug administration', 'level': 2, 'score': 0.6489373}, {'id': 'https://openalex.org/C2910001868', 'wikidata': 'https://www.wikidata.org/wiki/Q458', 'display_name': 'European union', 'level': 2, 'score': 0.6407544}, {'id': 'https://openalex.org/C108170787', 'wikidata': 'https://www.wikidata.org/wiki/Q3951828', 'display_name': 'Agency (philosophy)', 'level': 2, 'score': 0.57117033}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.46318507}, {'id': 'https://openalex.org/C2779974597', 'wikidata': 'https://www.wikidata.org/wiki/Q28448986', 'display_name': 'Clinical Practice', 'level': 2, 'score': 0.4446321}, {'id': 'https://openalex.org/C535046627', 'wikidata': 'https://www.wikidata.org/wiki/Q30612', 'display_name': 'Clinical trial', 'level': 2, 'score': 0.4161132}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.37975997}, {'id': 'https://openalex.org/C512399662', 'wikidata': 'https://www.wikidata.org/wiki/Q3505712', 'display_name': 'Family medicine', 'level': 1, 'score': 0.3721912}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.35309267}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.3201571}, {'id': 'https://openalex.org/C138885662', 'wikidata': 'https://www.wikidata.org/wiki/Q5891', 'display_name': 'Philosophy', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C111472728', 'wikidata': 'https://www.wikidata.org/wiki/Q9471', 'display_name': 'Epistemology', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C144133560', 'wikidata': 'https://www.wikidata.org/wiki/Q4830453', 'display_name': 'Business', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C105639569', 'wikidata': 'https://www.wikidata.org/wiki/Q582577', 'display_name': 'Economic policy', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D017277', 'descriptor_name': 'Drug Approval', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D017277', 'descriptor_name': 'Drug Approval', 'qualifier_ui': 'Q000331', 'qualifier_name': 'legislation & jurisprudence', 'is_major_topic': False}, {'descriptor_ui': 'D017277', 'descriptor_name': 'Drug Approval', 'qualifier_ui': 'Q000458', 'qualifier_name': 'organization & administration', 'is_major_topic': False}, {'descriptor_ui': 'D005060', 'descriptor_name': 'Europe', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014481', 'descriptor_name': 'United States', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014486', 'descriptor_name': 'United States Food and Drug Administration', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1200/jco.2010.34.1248', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S15137598', 'display_name': 'Journal of Clinical Oncology', 'issn_l': '0732-183X', 'issn': ['0732-183X', '1527-7755'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/21537038', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 7, 'referenced_works': ['https://openalex.org/W1975777549', 'https://openalex.org/W1976341670', 'https://openalex.org/W2002367988', 'https://openalex.org/W2041298800', 'https://openalex.org/W2079927812', 'https://openalex.org/W2088071212', 'https://openalex.org/W2110813871'], 'related_works': ['https://openalex.org/W4300705810', 'https://openalex.org/W4290794148', 'https://openalex.org/W4210357677', 'https://openalex.org/W3167258865', 'https://openalex.org/W2920600216', 'https://openalex.org/W2597209334', 'https://openalex.org/W2442880795', 'https://openalex.org/W2094117429', 'https://openalex.org/W2026337388', 'https://openalex.org/W1591825783'], 'abstract_inverted_index': {'The': [0], 'aims': [1], 'of': [2, 10, 29, 52, 84, 89, 98, 129, 176, 178, 194, 211, 218, 224], 'this': [3], 'study': [4], 'were': [5, 72, 134, 150, 221], 'to': [6, 34, 81, 165, 228], 'compare': [7], 'the': [8, 11, 17, 25, 44, 50, 58, 65, 102, 112, 118, 122, 130, 160, 179, 183, 190, 209, 212, 225, 235], 'approaches': [9], 'European': [12, 45, 59], 'Medicines': [13], 'Agency': [14], '(EMA)': [15], 'and': [16, 20, 27, 33, 63, 78, 132, 148, 192, 214], 'US': [18], 'Food': [19], 'Drug': [21], 'Administration': [22], '(FDA)': [23], 'in': [24, 139, 143, 174, 208], 'evaluation': [26], 'approval': [28, 169, 187, 216], 'new': [30], 'anticancer': [31, 53, 70], 'indications': [32, 48, 145], 'identify': [35], 'possible': [36], 'clinical': [37, 196], 'implications': [38], 'associated': [39], 'with': [40, 182], 'these': [41, 99], 'differences.Information': [42], 'on': [43, 239], 'Union': [46], 'therapeutic': [47, 144], 'for': [49, 198], 'cohort': [51], 'drugs': [54, 71], 'was': [55, 94, 104, 125, 163, 170], 'extracted': [56], 'from': [57, 64], 'Public': [60], 'Assessment': [61], 'Reports': [62], 'FDA': [66, 149, 215], 'review': [67], 'reports.Overall,': [68], '42': [69], 'approved': [73, 108, 126], 'by': [74, 127], 'EMA': [75, 147, 213], 'between': [76, 146, 243], '1995': [77], '2008,': [79], 'corresponding': [80], 'a': [82, 92, 167, 230], 'total': [83], '100': [85, 90], 'indications.': [86], 'In': [87], '47': [88, 100], 'indications,': [91, 101, 121], 'difference': [93, 103], 'found.': [95, 222], 'For': [96, 117], '19': [97], 'that': [105, 159, 162, 185], 'one': [106], 'agency': [107, 114, 161, 184], 'an': [109, 137, 156], 'indication,': [110], 'whereas': [111], 'other': [113], 'did': [115], 'not.': [116], 'remaining': [119], '28': [120], 'same': [123], 'indication': [124, 180], 'both': [128], 'agencies': [131, 226], 'differences': [133, 207], 'evaluated': [135], 'through': [136], 'algorithm;': [138], '10': [140], 'cases,': [141], 'discrepancies': [142], 'considered': [151], 'clinically': [152], 'relevant.': [153], 'We': [154], 'found': [155], 'overall': [157], 'trend': [158], 'second': [164], 'give': [166], 'positive': [168], 'usually': [171], 'more': [172], 'restrictive': [173, 232], 'terms': [175], 'wording': [177], 'compared': [181], 'provided': [186], 'first.': [188], 'Regarding': [189], 'use': [191], 'robustness': [193], 'available': [195], 'data': [197], 'evaluation,': [199], 'no': [200], 'clear': [201], 'associations': [202], 'could': [203], 'be': [204], 'found.Clinically': [205], 'relevant': [206], 'outcome': [210], 'process': [217], 'oncology': [219], 'products': [220], 'Neither': [223], 'seems': [227], 'have': [229], 'prevailing': [231], 'behavior': [233], 'over': [234], 'other.': [236], 'Further': [237], 'efforts': [238], 'harmonizing': [240], 'decision': [241], 'making': [242], 'regulatory': [244], 'systems': [245], 'are': [246], 'needed.': [247]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1989308735', 'counts_by_year': [{'year': 2024, 'cited_by_count': 3}, {'year': 2023, 'cited_by_count': 6}, {'year': 2022, 'cited_by_count': 3}, {'year': 2021, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 7}, {'year': 2019, 'cited_by_count': 3}, {'year': 2018, 'cited_by_count': 7}, {'year': 2017, 'cited_by_count': 2}, {'year': 2016, 'cited_by_count': 10}, {'year': 2015, 'cited_by_count': 5}, {'year': 2014, 'cited_by_count': 6}, {'year': 2013, 'cited_by_count': 12}, {'year': 2012, 'cited_by_count': 5}], 'updated_date': '2024-12-13T04:14:28.058344', 'created_date': '2016-06-24'}